Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
REDWOOD CITY, CA--(Marketwired - May 2, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
-
REDWOOD CITY, CA--(Marketwired - May 2, 2016) - Graybug Vision, a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases including wet...
-
REDWOOD CITY, CA--(Marketwired - Apr 25, 2016) - Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases...
-
BALTIMORE, MD--(Marketwired - Feb 4, 2016) - GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of ocular...
-
BALTIMORE, MD--(Marketwired - Jan 29, 2016) - GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of...
-
BALTIMORE, MD--(Marketwired - Jan 7, 2016) - GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of ocular...
-
BALTIMORE, MD--(Marketwired - Nov 12, 2015) - GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of ocular...